Digital communication channels are subject to the monitoring obligation of drug safety (pharmacovigilance) just like conventional channels. However, the numerous new channels of communication can only be monitored in conformity with the law with profound technical knowledge, coupled with the know-how of pharmacovigilance.
An important element of pharmacovigilance is the reporting of adverse drug reactions (ADRs) to the competent authorities.
Regardless of which digital project you would like to implement, we would be happy to take over the monitoring for you, in a highly efficient and economical manor.
By using our pharmacovigilance service software evalii, we offer the audit-compliant, efficient, and safe solution to monitor even high-frequency channels.
We now offer this service in 41 countries. Contact us for further information or find out more at: www.evalii.de.